Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -2.365M
March 31, 2026 -1.695M
December 31, 2025 -1.30M
September 30, 2025 -0.2365M
June 30, 2025 -0.0395M
March 31, 2025 0.2259M
December 31, 2024 -0.0577M
September 30, 2024 -0.688M
June 30, 2024 -0.6944M
March 31, 2024 -0.8801M
December 31, 2023 -1.677M
September 30, 2023 -2.031M
June 30, 2023 -2.036M
March 31, 2023 -1.540M
December 31, 2022 -0.2685M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020 -6.566M
June 30, 2020 -0.0453M
Date Value
March 31, 2020 -0.0362M
December 31, 2019 -0.0412M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015 -1.547M
June 30, 2015 -0.0089M
March 31, 2015 -0.0167M
December 31, 2014 -0.0786M
September 30, 2014 -0.3618M
June 30, 2014 -0.3528M
March 31, 2014 -0.3442M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
PD-Rx Pharmaceuticals, Inc. --
Acro Biomedical Co. Ltd. -0.1401M
DataMeds AI, Inc. -13.74M
Interpace Biosciences, Inc. 4.457M
Medical Marijuana, Inc. -0.3957M